Form EFFECT Kailera Therapeutics,

April 17, 2026 6:06 AM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 16, 2026 4:00 P.M.
Form: S-1
CIK: 0002096997
Company Name: Kailera Therapeutics, Inc.
File Number: 333-294690


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings